Company Quick10K Filing
Quick10K
Praxair
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2018-11-09 Earnings, Exhibits
8-K 2018-10-31 M&A, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K 2018-10-22 Other Events, Exhibits
8-K 2018-10-16 Officers, Exhibits
8-K 2018-09-07 Suspend Trading, Exhibits
8-K 2018-07-26 Earnings, Exhibits
8-K 2018-07-05 Enter Agreement
8-K 2018-04-06 Officers
8-K 2018-02-16 Other Events
8-K 2018-01-29 Other Events, Exhibits
8-K 2018-01-25 Earnings, Exhibits
CTSH Cognizant 33,640
STI Suntrust Banks 28,140
CAR Avis Budget Group 2,630
MMI Marcus & Millichap 1,390
NINE Nine Energy Service 678
PRTA Prothena 418
JRSH Jerash 79
CLSD Clearside Biomedical 45
YOGA Yogaworks 15
AHPA Avista Healthcare Public Acquisition 0
PX 2018-09-30
Note 16. Income Taxes
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
EX-2.1 px-20180930xex21.htm
EX-31.01 px-20180930xex3101.htm
EX-31.02 px-20180930xex3102.htm
EX-32.01 px-20180930xex3201.htm
EX-32.02 px-20180930xex3202.htm

Praxair Earnings 2018-09-30

PX 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

10-Q 1 px-q3201810q.htm 10-Q Document

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to
PRAXAIR, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
1-11037
 
06-1249050
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
10 Riverview Drive, DANBURY, CT
 
06810-6268
(Address of principal executive offices)
 
(Zip Code)
(203) 837-2000
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class: Registered on:
Common Stock ($0.01 par value) New York Stock Exchange
1.50% Euro notes due 2020 New York Stock Exchange
1.20% Euro notes due 2024 New York Stock Exchange
1.625% Euro notes due 2025 New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
¨
Smaller reporting company
 
¨
 
 
 
Emerging growth company
 
¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
¨
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨    No  ý
At September 30, 2018, 287,856,237 shares of common stock ($0.01 par value) of the Registrant were outstanding.
 



INTRODUCTORY NOTE

On October 31, 2018, Praxair, Inc. (“Praxair” or the “Company”) and Linde Aktiengesellschaft, a stock corporation incorporated under the laws of Germany (“Linde AG”), combined under Linde plc, a public limited company incorporated under the laws of Ireland (“Linde plc”), as contemplated by the business combination agreement, dated June 1, 2017, as amended on August 10, 2017 (the “Business Combination Agreement”), by and among the Company, Linde AG, Linde plc, Zamalight Holdco LLC and Zamalight Subco, Inc. Pursuant to the Business Combination Agreement, (i) Praxair became an indirect wholly-owned subsidiary of Linde plc through the merger of Zamalight Subco, Inc., an indirect wholly-owned Delaware subsidiary of Linde plc with and into Praxair, and (ii) Linde AG became an indirect subsidiary of Linde plc through an exchange offer by Linde plc for each issued and outstanding bearer share of Linde AG. On October 31, 2018, Linde plc filed a Current Report on Form 8-K with the Securities and Exchange Commission (“SEC”) that established Linde plc as the successor issuer to Praxair under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

This Quarterly Report on Form 10-Q relates to the Company's quarter ended September 30, 2018, which was prior to the completion of the Business Combination.




INDEX
 
 
PART I - FINANCIAL INFORMATION
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
Item 5.
 
 
 
Item 6.
 
 
 
 





PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Millions of dollars, except per share data)
(UNAUDITED) 

 
Quarter Ended September 30,
 
2018
 
2017
SALES
$
3,024

 
$
2,922

Cost of sales, exclusive of depreciation and amortization
1,714

 
1,652

Selling, general and administrative
294

 
300

Depreciation and amortization
306

 
298

Research and development
23

 
23

Transaction costs and other charges
31

 
14

Other income (expense) - net
13

 
(3
)
OPERATING PROFIT
669

 
632

Interest expense - net
40

 
41

Net pension and OPEB cost (benefit), excluding service cost
6

 
6

INCOME BEFORE INCOME TAXES AND EQUITY INVESTMENTS
623

 
585

Income taxes
156

 
162

INCOME BEFORE EQUITY INVESTMENTS
467

 
423

Income from equity investments
13

 
12

NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
480

 
435

Less: noncontrolling interests
(19
)
 
(16
)
NET INCOME - PRAXAIR, INC.
$
461

 
$
419

PER SHARE DATA - PRAXAIR, INC. SHAREHOLDERS
 
 
 
Basic earnings per share
$
1.60

 
$
1.46

Diluted earnings per share
$
1.58

 
$
1.45

WEIGHTED AVERAGE SHARES OUTSTANDING (000’s):
 
 
 
Basic shares outstanding
288,093

 
286,467

Diluted shares outstanding
291,513

 
289,216

The accompanying notes are an integral part of these financial statements.


3


PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Millions of dollars, except per share data)
(UNAUDITED)
 
 
Nine months ended September 30,
 
2018
 
2017
SALES
$
9,084

 
$
8,484

Cost of sales, exclusive of depreciation and amortization
5,114

 
4,800

Selling, general and administrative
911

 
895

Depreciation and amortization
928

 
877

Research and development
71

 
69

Transaction costs and other charges

74

 
35

Other income (expense) - net
25

 
(3
)
OPERATING PROFIT
2,011

 
1,805

Interest expense - net
130

 
120

Net pension and OPEB cost (benefit), excluding service cost
10

 
(7
)
INCOME BEFORE INCOME TAXES AND EQUITY INVESTMENTS
1,871

 
1,692

Income taxes
462

 
468

INCOME BEFORE EQUITY INVESTMENTS
1,409

 
1,224

Income from equity investments
42

 
35

NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
1,451

 
1,259

Less: noncontrolling interests
(48
)
 
(45
)
NET INCOME - PRAXAIR, INC.
$
1,403

 
$
1,214

PER SHARE DATA - PRAXAIR, INC. SHAREHOLDERS
 
 
 
Basic earnings per share
$
4.87

 
$
4.24

Diluted earnings per share
$
4.82

 
$
4.21

WEIGHTED AVERAGE SHARES OUTSTANDING (000’s):
 
 
 
Basic shares outstanding
287,800

 
286,022

Diluted shares outstanding
291,275

 
288,524

The accompanying notes are an integral part of these financial statements.


4


PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Millions of dollars)
(UNAUDITED)
 
 
Quarter Ended September 30,
 
2018
 
2017
NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
$
480

 
$
435

 
 
 
 
OTHER COMPREHENSIVE INCOME (LOSS)
 
 
 
Translation adjustments:
 
 
 
Foreign currency translation adjustments
(89
)
 
204

Income taxes
2

 
19

Translation adjustments
(87
)
 
223

Funded status - retirement obligations (Note 11):
 
 
 
Retirement program remeasurements
3

 
(9
)
Reclassifications to net income
22

 
19

Income taxes
(5
)
 
(4
)
Funded status - retirement obligations
20

 
6

Derivative instruments (Note 6):
 
 
 
Current quarter unrealized gain (loss)

 

Reclassifications to net income

 

Income taxes

 

Derivative instruments

 

TOTAL OTHER COMPREHENSIVE INCOME (LOSS)
(67
)
 
229

 
 
 
 
COMPREHENSIVE INCOME (LOSS) (INCLUDING NONCONTROLLING INTERESTS)
413

 
664

Less: noncontrolling interests
(12
)
 
(26
)
COMPREHENSIVE INCOME (LOSS) - PRAXAIR, INC.
$
401

 
$
638

The accompanying notes are an integral part of these financial statements.


5


PRAXAIR, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Millions of dollars)
(UNAUDITED)
 
 
Nine months ended September 30,
 
2018
 
2017
NET INCOME (INCLUDING NONCONTROLLING INTERESTS)
$
1,451

 
$
1,259

 
 
 
 
OTHER COMPREHENSIVE INCOME (LOSS)
 
 
 
Translation adjustments:
 
 
 
 Foreign currency translation adjustments
(623
)
 
520

 Income taxes
8

 
77

Translation adjustments
(615
)
 
597

Funded status - retirement obligations (Note 11):
 
 
 
Retirement program remeasurements
(5
)
 
(29
)
Reclassifications to net income
56

 
39

Income taxes
(11
)
 
(4
)
Funded status - retirement obligations
40

 
6

Derivative instruments (Note 6):
 
 
 
Current period unrealized gain (loss)

 

Reclassifications to net income

 

Income taxes

 

Derivative instruments

 

TOTAL OTHER COMPREHENSIVE INCOME (LOSS)
(575
)
 
603

 
 
 
 
COMPREHENSIVE INCOME (LOSS) (INCLUDING NONCONTROLLING INTERESTS)
876

 
1,862

Less: noncontrolling interests
(31
)
 
(73
)
COMPREHENSIVE INCOME (LOSS) - PRAXAIR, INC.
$
845

 
$
1,789

The accompanying notes are an integral part of these financial statements.


6


PRAXAIR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Millions of dollars)
(UNAUDITED)
 
 
September 30, 2018
 
December 31, 2017
ASSETS
 
 
 
Cash and cash equivalents
$
600

 
$
617

Accounts receivable - net
1,852

 
1,804

Inventories
622

 
614

Prepaid and other current assets
231

 
250

TOTAL CURRENT ASSETS
3,305

 
3,285

Property, plant and equipment (less accumulated depreciation of $13,987 in 2018 and $13,819 in 2017)
11,725

 
12,057

Goodwill
3,201

 
3,233

Other intangible assets - net
513

 
553

Other long-term assets
1,235

 
1,308

TOTAL ASSETS
$
19,979

 
$
20,436

LIABILITIES AND EQUITY
 
 
 
Accounts payable
$
978

 
$
972

Short-term debt
115

 
238

Current portion of long-term debt
1,582

 
979

Other current liabilities
1,185

 
1,118

TOTAL CURRENT LIABILITIES
3,860

 
3,307

Long-term debt
6,615

 
7,783

Other long-term liabilities
2,754

 
2,824

TOTAL LIABILITIES
13,229

 
13,914

Commitments and contingencies (Note 12)


 


Redeemable noncontrolling interests (Note 14)
15

 
11

Praxair, Inc. Shareholders’ Equity:
 
 
 
Common stock $0.01 par value, authorized - 800,000,000 shares, issued 2018 and 2017 - 383,230,625 shares
4

 
4

Additional paid-in capital
4,088

 
4,084

Retained earnings
13,913

 
13,224

Accumulated other comprehensive income (loss) (Note 14)
(4,656
)
 
(4,098
)
Less: Treasury stock, at cost (2018 - 95,374,388 shares and 2017 - 96,453,634 shares)
(7,117
)
 
(7,196
)
Total Praxair, Inc. Shareholders’ Equity
6,232

 
6,018

Noncontrolling interests
503

 
493

TOTAL EQUITY
6,735

 
6,511

TOTAL LIABILITIES AND EQUITY
$
19,979

 
$
20,436

The accompanying notes are an integral part of these financial statements.


7


PRAXAIR, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Millions of dollars)
(UNAUDITED)
 
 
Nine months ended September 30,
 
2018
 
2017
OPERATIONS
 
 
 
Net income - Praxair, Inc.
$
1,403

 
$
1,214

Noncontrolling interests
48

 
45

Net income (including noncontrolling interests)
1,451

 
1,259

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Transaction costs and other charges, net of payments
35

 
27

Depreciation and amortization
928

 
877

Deferred income taxes
(6
)
 
22

Share-based compensation
40

 
44

Working capital:
 
 
 
Accounts receivable
(121
)
 
(83
)
Inventory
(29
)
 
(11
)
Prepaid and other current assets
3

 
(64
)
Payables and accruals
101

 
11

Pension contributions
(17
)
 
(14
)
Long-term assets, liabilities and other
(36
)
 
137

Net cash provided by operating activities
2,349

 
2,205

INVESTING
 
 
 
Capital expenditures
(1,056
)
 
(972
)
Acquisitions, net of cash acquired
(6
)
 
(18
)
Divestitures and asset sales
77

 
22

Net cash used for investing activities
(985
)
 
(968
)
FINANCING
 
 
 
Short-term debt borrowings (repayments) - net
(122
)
 
(353
)
Long-term debt borrowings
2

 
11

Long-term debt repayments
(505
)
 
(160
)
Issuances of common stock
70

 
90

Purchases of common stock
(2
)
 
(11
)
Cash dividends - Praxair, Inc. shareholders
(712
)
 
(675
)
Noncontrolling interest transactions and other
(33
)
 
(85
)
Net cash provided by (used for) financing activities
(1,302
)
 
(1,183
)
Effect of exchange rate changes on cash and cash equivalents
(79
)
 
29

Change in cash and cash equivalents
(17
)
 
83

Cash and cash equivalents, beginning-of-period
617

 
524

Cash and cash equivalents, end-of-period
$
600

 
$
607

The accompanying notes are an integral part of these financial statements.

8


INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Notes to Condensed Consolidated Financial Statements - Praxair, Inc. and Subsidiaries (Unaudited)
 


9


PRAXAIR, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. Summary of Significant Accounting Policies
Presentation of Condensed Consolidated Financial Statements - In the opinion of Praxair, Inc. (Praxair) management, the accompanying condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods presented and such adjustments are of a normal recurring nature. The accompanying condensed consolidated financial statements should be read in conjunction with the notes to the consolidated financial statements of Praxair, Inc. and subsidiaries in Praxair’s 2017 Annual Report on Form 10-K. There have been no material changes to the company’s significant accounting policies during 2018.
Accounting Standards Implemented in 2018
Revenue Recognition – In May 2014, the FASB issued updated guidance on the reporting and disclosure of revenue. Effective January 1, 2018, Praxair has adopted this guidance using the modified retrospective transition method. No material differences in revenue recognition accounting were identified under the new guidance compared with the Company's historic revenue recognition accounting (see Note 15).
Classification of Certain Cash Receipts and Cash Payments – In August 2016, the FASB issued updated guidance on the classification of certain cash receipts and cash payments within the statement of cash flows. The update provides accounting guidance for specific cash flow issues with the objective of reducing diversity in practice. The adoption of this guidance did not have a material impact on the financial statements.
Intra-Entity Asset Transfers – In October 2016, the FASB issued updated guidance for income tax accounting of intra-entity transfers of assets other than inventory. The update requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory in the period when the transfer occurs. The adoption of this guidance did not have a material impact on the financial statements.
Pension Costs - In March 2017, the FASB issued updated guidance on the presentation of net periodic pension cost and net periodic postretirement benefit cost. The new guidance requires the service cost component be reported in the same line item or items as other compensation costs arising from services rendered by employees during the period. The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and not included within operating profit. This guidance was adopted in the first quarter 2018. Accordingly, non-service related components of net periodic pension and postretirement benefit costs were reclassified out of "Operating Profit" to "Net pension and OPEB cost (benefit), excluding service cost" using the practical expedient to use the amounts disclosed in the retirement benefits note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements (see Note 11).

Accounting Standards to be Implemented

Leases – In February 2016, the FASB issued updated guidance on the accounting and financial statement presentation of leases. The new guidance requires lessees to recognize a right-of-use asset and lease liability for all leases, except those that meet certain scope exceptions, and would require expanded quantitative and qualitative disclosures. This guidance will be effective for Praxair beginning in the first quarter 2019 and requires companies to transition using a modified retrospective approach. Praxair is in the process of implementing the new guidance and will provide updates on the expected impact to Praxair in future filings, as appropriate.
Credit Losses on Financial Instruments In June 2016, the FASB issued an update on the measurement of credit losses. The guidance introduces a new accounting model for expected credit losses on financial instruments, including trade receivables, based on estimates of current expected credit losses. This guidance will be effective for Praxair beginning in the first quarter 2020, with early adoption permitted beginning in the first quarter 2019 and requires companies to apply the change in accounting on a prospective basis. We are currently evaluating the impact this update will have on our consolidated financial statements.
Simplifying the Test for Goodwill Impairment – In January 2017, the FASB issued updated guidance on the measurement of goodwill. The new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. The guidance will be effective for Praxair beginning in the first quarter 2020. Praxair does not expect this guidance to have a material impact.

10


Derivatives and Hedging - In August 2017, the FASB issued updated guidance on accounting for hedging activities. The new guidance changes both the designation and measurement for qualifying hedging relationships and the presentation of hedge results. This guidance will be effective for Praxair beginning in the first quarter 2019, with early adoption optional. Praxair is currently evaluating the impact this update will have on our consolidated financial statements.
Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income – In February 2018, the FASB issued updated guidance which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. This new guidance will be effective for Praxair beginning in the first quarter 2019 on a retrospective basis, with early adoption optional. Praxair is currently assessing the impact and timing of adoption.
Reclassifications – Certain prior years’ amounts have been reclassified to conform to the current year’s presentation including reclassifications on the consolidated statements of income and segment operating profit relating to the adoption of accounting guidance on the presentation of net periodic pension and postretirement benefit costs.
2. Transaction Costs and Other Charges

Transaction costs and other charges were $31 million and $74 million ($29 million and $67 million after-tax and noncontrolling interest, or $0.10 and $0.23 per diluted share) for the quarter and nine months ended September 30, 2018, respectively. Transaction costs and other charges were $14 million and $35 million ($13 million and $34 million after-tax or $0.05 and $0.12 per diluted share) for the quarter and nine months ended September 30, 2017.

On October 31, 2018, Praxair and Linde AG combined under Linde plc, as contemplated by the Business Combination Agreement (see Note 17). Praxair incurred transaction costs and other charges primarily in connection with the intended business combination totaling $21 million and $64 million for the quarter and nine months ended September 30, 2018 ($19 million and $57 million after-tax and noncontrolling interests, or $0.07 and $0.20 per diluted share), respectively. Praxair incurred transaction costs which totaled $14 million and $35 million for the quarter and nine months ended September 30, 2017 ($13 million and $34 million after-tax, or $0.05 and $0.12 per diluted share), respectively.

Effective July 1, 2018, Argentina was deemed a highly inflationary economy. As a result, the third quarter of 2018 includes a $10 million charge ($10 million after-tax, or $0.03 per diluted share) associated with the transition to hyper-inflationary accounting in Argentina.

Classification in the condensed consolidated financial statements
The costs are shown within operating profit in a separate line item on the consolidated statements of income. On the condensed consolidated statement of cash flows, the impact of these costs, net of cash payments, is shown as an adjustment to reconcile net income to net cash provided by operating activities. In Note 13 - Segments, Praxair excluded these costs from its management definition of segment operating profit; a reconciliation of segments operating profit to consolidated operating profit is shown within the segment operating profit table.
 
3. Acquisitions
During the nine months ended September 30, 2018 and 2017, Praxair had acquisitions totaling $6 million and $18 million, respectively, related primarily to acquisitions of packaged gas businesses in North America.





11




4. Supplemental Information
Inventories
The following is a summary of Praxair’s consolidated inventories:
(Millions of dollars)
September 30,
2018
 
December 31,
2017
Inventories
 
 
 
Raw materials and supplies
$
218

 
$
224

Work in process
54

 
57

Finished goods
350

 
333

Total inventories
$
622

 
$
614


Long-term receivables
Long-term receivables are not material and are largely reserved. Such long-term receivables are included within other long-term assets in the condensed consolidated balance sheets and totaled $31 million and $54 million at September 30, 2018 and December 31, 2017, respectively. These amounts are net of reserves of $45 million and $51 million, respectively. The amounts in both periods relate primarily to government receivables in Brazil and other long-term notes receivable from customers. Collectability is reviewed regularly and uncollectible amounts are written off as appropriate.


12


5. Debt
The following is a summary of Praxair’s outstanding debt at September 30, 2018 and December 31, 2017:
(Millions of dollars)
September 30,
2018
 
December 31,
2017
SHORT-TERM
 
 
 
Commercial paper and U.S. bank borrowings
$
83

 
$
202

Other bank borrowings (primarily international)
32

 
36

Total short-term debt
115

 
238

LONG-TERM (a)
 
 
 
U.S. borrowings (U.S. dollar denominated unless otherwise noted)
 
 
 
1.20% Notes due 2018 (b)

 
498

1.25% Notes due 2018 (b, c)
475

 
475

1.90% Notes due 2019
500

 
500

4.50% Notes due 2019
599

 
599

1.50% Euro-denominated notes due 2020
694

 
717

2.25% Notes due 2020
299

 
299

4.05% Notes due 2021
499

 
498

3.00% Notes due 2021
498

 
497

2.45% Notes due 2022
598

 
598

2.20% Notes due 2022
498

 
498

2.70% Notes due 2023
498

 
498

1.20% Euro-denominated notes due 2024
636

 
658

2.65% Notes due 2025
398

 
397

1.625% Euro-denominated notes due 2025
574

 
594

3.20% Notes due 2026
725

 
725

3.55% Notes due 2042
662

 
662

Other
10

 
12

International bank borrowings
31

 
33

Obligations under capital leases
3

 
4

 
8,197

 
8,762

Less: current portion of long-term debt
(1,582
)
 
(979
)
Total long-term debt
6,615

 
7,783

Total debt
$
8,312

 
$
9,000

 
(a)
Amounts are net of unamortized discounts, premiums and/or debt issuance costs as applicable.
(b)
In March 2018, Praxair repaid $500 million of 1.20% notes that became due. On November 7, 2018, Praxair repaid $475 million of 1.25% notes that became due.
(c)
September 30, 2018 and December 31, 2017 include a less than $1 million fair value decrease and a less than $1 million increase, respectively, related to hedge accounting. See Note 6 for additional information.
In June 2018, the company's $500 million 364-day revolving credit facility with a syndicate of banks expired and was not renewed.

6. Financial Instruments
In its normal operations, Praxair is exposed to market risks relating to fluctuations in interest rates, foreign currency exchange rates, energy costs and to a lesser extent precious metal prices. The objective of financial risk management at Praxair is to minimize the negative impact of such fluctuations on the company’s earnings and cash flows. To manage these risks, among other strategies, Praxair routinely enters into various derivative financial instruments (“derivatives”) including interest-rate swap and treasury rate lock agreements, currency-swap agreements, forward contracts, currency options, and commodity-swap agreements. These instruments are not entered into for trading purposes and Praxair only uses commonly traded and non-leveraged instruments.
There are three types of derivatives that the company enters into: (i) those relating to fair-value exposures, (ii) those relating to cash-flow exposures, and (iii) those relating to foreign currency net investment exposures. Fair-value exposures relate to

13


recognized assets or liabilities, and firm commitments; cash-flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions; and net investment exposures relate to the impact of foreign currency exchange rate changes on the carrying value of net assets denominated in foreign currencies.
When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair-value hedge, cash-flow hedge, or a net investment hedge. Currently, Praxair designates all interest-rate and treasury-rate locks as hedges for accounting purposes; however, currency contracts are generally not designated as hedges for accounting purposes unless they are related to forecasted transactions. Whether designated as hedges for accounting purposes or not, all derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the company assesses the hedge effectiveness of all derivatives designated as hedges for accounting purposes to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.
Counterparties to Praxair’s derivatives are major banking institutions with credit ratings of investment grade or better and no collateral is required, and there are no significant risk concentrations. Management believes the risk of incurring losses on derivative contracts related to credit risk is remote and any losses would be immaterial.
The following table is a summary of the notional amount and fair value of derivatives outstanding at September 30, 2018 and December 31, 2017 for consolidated subsidiaries:
 
 
 
 
 
Fair Value
 
Notional Amounts
 
Assets
 
Liabilities
(Millions of dollars)
September 30,
2018
 
December 31,
2017
 
September 30,
2018
 
December 31,
2017
 
September 30,
2018
 
December 31,
2017
Derivatives Not Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
Currency contracts:
 
 
 
 
 
 
 
 
 
 
 
Balance sheet items (a)
$
2,099

 
$
2,693

 
$
16

 
$
16

 
$
6

 
$
16

Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
Currency contracts:
 
 
 
 
 
 
 
 
 
 
 
Balance sheet items (a)
$

 
$
38

 
$

 
$

 
$

 
$
2

       Forecasted purchases (a)
6

 
4

 

 
1

 

 

Interest rate contracts:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps (a, b)
475

 
475

 

 

 

 

Total Hedges
$
481

 
$
517

 
$

 
$
1

 
$

 
$
2

Total Derivatives
$
2,580

 
$
3,210

 
$
16

 
$
17

 
$
6

 
$
18

 
(a)
Assets are recorded in prepaid and other current assets, and liabilities are recorded in other current liabilities.
(b)
On November 7, 2018, Praxair repaid $475 million of 1.25% notes that became due and the associated interest rate swap was settled.
 

Currency Contracts
Balance Sheet Items
Foreign currency contracts related to balance sheet items consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on recorded balance sheet assets and liabilities denominated in currencies other than the functional currency of the related operating unit. Certain forward currency contracts are entered into to protect underlying monetary assets and liabilities denominated in foreign currencies from foreign exchange risk and are not designated as hedging instruments. The fair value adjustments on these contracts are offset by the fair value adjustments recorded on the underlying monetary assets and liabilities. Praxair also enters into forward currency contracts, which are designated as hedging instruments, to limit the cash flow exposure on certain foreign-currency denominated intercompany loans. The fair value adjustments on these contracts are recorded to AOCI, with the effective portion immediately reclassified to earnings to offset the fair value adjustments on the underlying debt instrument.
Forecasted Purchases
Foreign currency contracts related to forecasted purchases consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on forecasted purchases of capital-related equipment and services denominated

14


in currencies other than the functional currency of the related operating units. These forward contracts were designated and accounted for as cash flow hedges.
Net Investment Hedge

As of September 30, 2018, the Company has €1.65 billion ($1.92 billion) of Euro-denominated notes, of which €1.63 billion ($1.89 billion) is designated as a hedge of the net investment position in its European operations. These Euro-denominated debt instruments reduce the company's exposure to changes in the currency exchange rate on investments in foreign subsidiaries with Euro functional currencies. Since hedge inception, exchange rate movements have reduced long-term debt by $162 million (long-term debt decreased by $65 million during the first nine months of 2018), with the offsetting gain shown within the cumulative translation component of AOCI in the condensed consolidated balance sheets and the consolidated statements of comprehensive income.
Interest Rate Contracts
Outstanding Interest Rate Swaps
At September 30, 2018, Praxair had one outstanding interest rate swap agreement with a $475 million notional amount related to the $475 million 1.25% notes that matured on November 7, 2018. The interest rate swap effectively converts fixed-rate interest to variable-rate interest and is designated as a fair value hedge. Fair value adjustments are recognized in earnings along with an equally offsetting charge / benefit to earnings for the changes in the fair value of the underlying debt instrument. At September 30, 2018, less than $1 million was recognized as a decrease in the fair value of these notes (increase in the fair value of less than $1 million at December 31, 2017).

Terminated Treasury Rate Locks
The following table summarizes the unrecognized gains (losses) related to terminated treasury rate lock contracts:
 
Year
Terminated
 
Original
Gain /
(Loss)
 
Unrecognized Gain / (Loss) (a)
(Millions of dollars)
September 30,
2018
 
December 31,
2017
Treasury Rate Locks
 
 
 
 
 
 
 
Underlying debt instrument:
 
 
 
 
 
 
 
$500 million 2.20% fixed-rate notes that mature in 2022 (b)
2012
 
$
(2
)
 
$

 
$
(1
)
$500 million 3.00% fixed-rate notes that mature in 2021 (b)
2011
 
(11
)
 
(3
)
 
(4
)
$600 million 4.50% fixed-rate notes that mature in 2019 (b)
2009
 
16

 
1

 
3

       Total - pre-tax
 
 
 
 
$
(2
)
 
$
(2
)
Less: income taxes
 
 
 
 
1

 
1

After- tax amounts
 
 
 
 
$
(1
)
 
$
(1
)
 
(a)
The unrecognized gains / (losses) for the treasury rate locks are shown in accumulated other comprehensive income (“AOCI”) and are being recognized on a straight line basis to interest expense – net over the term of the underlying debt agreements. Refer to the table below summarizing the impact on the company’s consolidated statements of income and AOCI for current period gain (loss) recognition.
(b)
The notional amount of the treasury rate lock contracts are equal to the underlying debt instrument with the exception of the treasury rate lock contract entered into to hedge the $600 million 4.50% fixed-rate notes that mature in 2019. The notional amount of this contract was $500 million.


15


The following table summarizes the impact of the company’s derivatives on the consolidated statements of income:
 
Amount of Pre-Tax Gain (Loss)
Recognized in Earnings *
 
Quarter Ended September 30,
 
Nine Months Ended September 30,
(Millions of dollars)
2018
 
2017
 
2018
 
2017
Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
Currency contracts:
 
 
 
 
 
 
 
Balance sheet items
 
 
 
 
 
 
 
Debt-related
$
17

 
$
19

 
$
(15
)
 
$
128

Other balance sheet items
3

 
(1
)
 
4

 
1

Total
$
20

 
$
18

 
$
(11
)
 
$
129


* The gains (losses) on balance sheet items are offset by gains (losses) recorded on the underlying hedged assets and liabilities. Accordingly, the gains (losses) for the derivatives and the underlying hedged assets and liabilities related to debt items are recorded in the consolidated statements of income as interest expense-net. Other balance sheet items and anticipated net income gains (losses) are recorded in the consolidated statements of income as other income (expenses)-net.

The following table summarizes the impacts of the company's derivatives designated as hedging instruments that impact AOCI:

Derivatives Designated as Hedging Instruments **
 
Quarter Ended
 
Amount of Gain  (Loss)
Recognized in AOCI
 
Amount of Gain  (Loss)
Reclassified from AOCI to the Consolidated Statement of
Income
(Millions of dollars)
September 30,
2018
 
September 30,
2017
 
September 30,
2018
 
September 30,
2017
Currency contracts:
 
 
 
 
 
 
 
Balance sheet items
$

 
$
(1
)
 
$

 
$

Forecasted purchases

 
1

 

 

Interest rate contracts:
 
 
 
 
 
 
 
Treasury rate lock contracts

 

 

 

Total - pre tax
$

 
$

 
$

 
$

Less: income taxes

 

 

 

Total - Net of Taxes
$

 
$

 
$

 
$


 
Nine Months Ended
 
Amount of Gain  (Loss)
Recognized in AOCI
 
Amount of Gain  (Loss)
Reclassified from AOCI to the Consolidated Statement of
Income
(Millions of dollars)
September 30,
2018
 
September 30,
2017
 
September 30,
2018
 
September 30,
2017
Currency contracts:
 
 
 
 
 
 
 
Balance sheet items
$

 
$
(1
)
 
$

 
$

Forecasted purchases

 
1

 

 

Interest rate contracts:
 
 
 
 
 
 
 
Treasury rate lock contracts

 

 

 

Total - pre tax
$

 
$

 
$

 
$

Less: income taxes

 

 

 

Total - Net of Taxes
$

 
$

 
$

 
$



**The gains (losses) on net investment hedges are recorded as a component of AOCI within foreign currency translation adjustments in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income. The gains (losses) on treasury rate locks are recorded as a

16


component of AOCI within derivative instruments in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income. There was no ineffectiveness for these instruments during 2018 or 2017. The gains (losses) on net investment hedges are reclassified to earnings only when the related currency translation adjustments are required to be reclassified, usually upon sale or liquidation of the investment. The gains (losses) for interest rate contracts are reclassified to earnings as interest expense –net on a straight-line basis over the remaining maturity of the underlying debt. Net losses of $1 million are expected to be reclassified to earnings during the next twelve months.

7. Fair Value Disclosures
The fair value hierarchy prioritizes the input to valuation techniques used to measure fair value into three broad levels as follows:
Level 1 – quoted prices in active markets for identical assets or liabilities
Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes assets and liabilities measured at fair value on a recurring basis:
 
Fair Value Measurements Using
 
Level 1
 
Level 2
 
Level 3
(Millions of dollars)
September 30,
2018
 
December 31,
2017
 
September 30,
2018
 
December 31,
2017
 
September 30,
2018
 
December 31,
2017
Assets
 
 
 
 
 
 
 
 
 
 
 
Derivatives

 

 
$
16

 
$
17

 

 

Liabilities
 
 
 
 
 
 
 
 
 
 
 
Derivatives

 

 
$
6

 
$
18

 

 

The fair values of the derivative assets and liabilities are based on market prices obtained from independent brokers or determined using quantitative models that use as their basis readily observable market parameters that are actively quoted and can be validated through external sources, including third-party pricing services, brokers and market transactions. Investments are marketable securities traded on an exchange.
The fair values of cash and cash equivalents, short-term debt, accounts receivable-net, and accounts payable approximate carrying amounts because of the short maturities of these instruments. The fair value of long-term debt is estimated based on the quoted market prices for similar issues, which is deemed a level 2 measurement. At September 30, 2018, the estimated fair value of Praxair’s long-term debt portfolio was $8,164 million versus a carrying value of $8,197 million. At December 31, 2017, the estimated fair value of Praxair’s long-term debt portfolio was $8,969 million versus a carrying value of $8,762 million. Differences from carrying amounts are attributable to interest-rate changes subsequent to when the debt was issued.

8. Earnings Per Share – Praxair, Inc. Shareholders
Basic earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding. Diluted earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding and dilutive common stock equivalents, as follows:

17


 
Quarter Ended September 30,
Nine Months Ended September 30,
 
2018
 
2017
2018
 
2017
Numerator (Millions of dollars)
 
 
 
 
 
 
Net income - Praxair, Inc.
$
461

 
$
419

$
1,403

 
$
1,214

Denominator (Thousands of shares)
 
 
 
 
 
 
Weighted average shares outstanding
287,752

 
286,103

287,465

 
285,654

Shares earned and issuable under compensation plans
341

 
364

335

 
368

Weighted average shares used in basic earnings per share
288,093

 
286,467

287,800

 
286,022

Effect of dilutive securities
 
 
 
 
 
 
Stock options and awards
3,420

 
2,749

3,475

 
2,502

Weighted average shares used in diluted earnings per share
291,513

 
289,216

291,275

 
288,524

Basic Earnings Per Share
$
1.60

 
$
1.46

$
4.87

 
$
4.24

Diluted Earnings Per Share
$
1.58

 
$
1.45

$
4.82

 
$
4.21

There were no antidilutive shares for the quarter and nine months ended September 30, 2018. There were no antidilutive shares for the quarter ended September 30, 2017. Stock options of 2,439,499 for nine months ended September 30, 2017 were antidilutive and therefore excluded in the computation of diluted earnings per share.
9. Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the nine months ended September 30, 2018 were as follows:
(Millions of dollars)
North
America
 
South
America
 
Europe
 
Asia
 
Surface
Technologies
 
Total
Balance, December 31, 2017
$
2,202

 
$
129

 
$
698

 
$
61

 
$
143

 
$
3,233

Acquisitions
3

 

 

 

 

 
3

Purchase adjustments & other
12

 

 

 

 

 
12

Foreign currency translation

 
(27
)
 
(16
)
 
(1
)
 
(3
)
 
(47
)
Balance, September 30, 2018
$
2,217

 
$
102

 
$
682

 
$
60

 
$
140

 
$
3,201


Praxair has performed its goodwill impairment tests annually during the second quarter of each year, and historically has determined that the fair value of each of its reporting units was substantially in excess of its carrying value. For the 2018 test completed last quarter, Praxair applied the FASB's accounting guidance which allows the Company to first assess qualitative factors to determine the extent of additional quantitative analysis, if any, that may be required to test goodwill for impairment (refer to Note 1 to the consolidated financial statements of Praxair's 2017 Annual Report on Form 10-K). Based on the qualitative assessments performed in the second quarter of 2018, Praxair concluded that it was more likely than not that the fair value of each reporting unit substantially exceeded its carrying value and therefore, further quantitative analysis was not required. As a result, no impairment was recorded. There were no indicators of impairment through September 30, 2018.
Changes in the carrying amounts of other intangibles for the nine months ended September 30, 2018 were as follows:

18


(Millions of dollars)
Customer &
License/Use
Agreements
 
Non-compete
Agreements
 
Patents &
Other
 
Total
Cost:
 
 
 
 
 
 
 
Balance, December 31, 2017
$
772

 
$
28

 
$
52

 
$
852

Additions
1

 
1

 

 
2

Foreign currency translation
(9
)
 

 
(1
)
 
(10
)
Other*
(20
)
 
(5
)
 

 
(25
)
Balance, September 30, 2018
$
744

 
$
24

 
$
51

 
$
819

Less: Accumulated amortization
 
 
 
 
 
 
 
Balance, December 31, 2017
$
(260
)
 
$
(18
)
 
$
(21
)
 
$
(299
)
Amortization expense
(28
)
 
(3
)
 
(3
)
 
(34
)
Foreign currency translation
3

 

 

 
3

Other*
19

 
5

 

 
24

Balance, September 30, 2018
$
(266
)
 
$
(16
)
 
$
(24
)
 
$
(306
)
Net balance at September 30, 2018
$
478

 
$
8

 
$
27

 
$
513


* Other primarily relates to the write-off of fully amortized assets.
There are no expected residual values related to these intangible assets. The remaining weighted-average amortization period for intangible assets is approximately 16 years.
Total estimated annual amortization expense is as follows:
(Millions of dollars)
 
Remaining 2018
$
11

2019
43

2020
41

2021
39

2022
38

Thereafter
341

 
$
513


19


10. Share-Based Compensation
Share-based compensation expense of $19 million and $16 million was recognized during the quarters ended September 30, 2018 and 2017, respectively. Share-based compensation of $40 million and $44 million was recognized during the nine months ended September 30, 2018 and 2017, respectively. The expense was recorded primarily in selling, general and administrative expenses. There was no share-based compensation cost that was capitalized. For further details regarding Praxair’s share-based compensation arrangements and prior-year grants, refer to Note 15 to the consolidated financial statements of Praxair’s 2017 Annual Report on Form 10-K.
Stock Options
The weighted-average fair value of options granted during the nine months ended September 30, 2018 was $19.29 ($12.40 in 2017) based on the Black-Scholes Options-Pricing model. The increase in grant date fair value year-over-year was primarily attributable to an increase in the company's stock price.

The following weighted-average assumptions were used to value the grants in 2018 and 2017:
 
Nine months ended September 30,
 
2018
 
2017
Dividend yield
2.1
%
 
2.7
%
Volatility
14.4
%
 
14.0
%
Risk-free interest rate
2.67
%
 
2.13
%
Expected term years
5

 
6

The following table summarizes option activity under the plans as of September 30, 2018 and changes during the nine-month period then ended (averages are calculated on a weighted basis; life in years; intrinsic value expressed in millions):
 
Number of
Options  (000’s)
 
Average
Exercise Price
 
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding at January 1, 2018
10,787

 
$
108.70

 
 
 
 
Granted
1,625

 
154.00

 
 
 
 
Exercised
(1,502
)
 
94.50

 
 
 
 
Cancelled or Expired
(63
)
 
128.91

 
 
 
 
Outstanding at September 30, 2018
10,847

 
117.34

 
6.2
 
$
471

Exercisable at September 30, 2018
7,143

 
$
110.46

 
5.0
 
$
359

The aggregate intrinsic value represents the difference between the company’s closing stock price of $160.73 as of September 30, 2018 and the exercise price multiplied by the number of in the money options outstanding as of that date. The total intrinsic value of stock options exercised during the quarter and nine months ended September 30, 2018 was $19 million and $96 million, respectively ($17 million and $80 million during the same periods in 2017, respectively).
Cash received from option exercises under all share-based payment arrangements for the quarter and nine months ended September 30, 2018 was $21 million and $59 million, respectively ($18 million and $81 million for the same periods in 2017). The cash tax benefit realized from share-based compensation totaled $9 million and $28 million for the quarter and nine months ended September 30, 2018, respectively ($5 million and $31 million for the same periods in 2017, respectively).
As of September 30, 2018, $26 million of unrecognized compensation cost related to non-vested stock options is expected to be recognized over a weighted-average period of approximately 1 year.
Performance-Based and Restricted Stock Awards
During the nine months ended September 30, 2018, the company granted restricted stock units to employees of 269,433 shares. There were no performance-based stock awards granted to employees during the nine months ended September 30, 2018 as restricted stock units were granted in place of performance-based stock awards. Compensation expense related to the restricted stock units is recognized over the vesting period, which is up to three years, based on the grant date fair value.
As of September 30, 2018 the company had performance-based stock awards outstanding, tied to either return on capital ("ROC") performance or relative total shareholder return ("TSR") performance versus that of the S&P 500. The actual number of shares issued in settlement of a vested award can range from zero to 200 percent of the target number of shares granted based upon the company’s attainment of specified performance targets at the end of a three-year period. Compensation expense

20


related to these awards is recognized over the three-year performance period based on the fair value of the closing market price of the company’s common stock on the date of the grant and the estimated performance that will be achieved. Compensation expense for ROC awards will be adjusted during the three-year performance period based upon the estimated performance levels that will be achieved. TSR awards are measured at their grant date fair value and not subsequently re-measured.
The weighted-average fair value of restricted stock units granted during the nine months ended September 30, 2018 was $144.79 ($111.70 for the same period in 2017). These fair values are based on the closing market price of Praxair’s common stock on the grant date adjusted for dividends that will not be paid during the vesting period. The weighted-average fair value of ROC performance-based stock awards granted during the nine months ended September 30, 2017 was $109.68.
The weighted-average fair value of performance-based stock tied to relative TSR performance granted during nine months ended September 30, 2017 was $124.12 and was estimated using a Monte Carlo simulation performed as of the grant date.
The following table summarizes non-vested performance-based and restricted stock award activity as of September 30, 2018 and changes during the nine months then ended (shares based on target amounts, averages are calculated on a weighted basis):
 
Performance-Based
 
Restricted Stock
 
Number  of
Shares
(000’s)
 
Average
Grant  Date
Fair Value
 
Number  of
Shares
(000’s)
 
Average
Grant  Date
Fair Value
Non-vested at January 1, 2018
665

 
$
113.40

 
264

 
$
107.56

Granted

 

 
269

 
144.79

Vested
(78
)
 
119.98

 
(89
)
 
116.22

Cancelled and Forfeited
(151
)
 
110.32

 
(17
)
 
100.23

Non-vested at September 30, 2018
436

 
$
110.02

 
427

 
$
129.52

There are approximately 6 thousand performance-based shares and 3 thousand restricted stock shares that are non-vested at September 30, 2018 which will be settled in cash due to foreign regulatory limitations. The liability related to these grants reflects the current estimate of performance that will be achieved and the current common stock price.
As of September 30, 2018, based on current estimates of future performance, $9 million of unrecognized compensation cost related to performance-based awards is expected to be recognized through the first quarter of 2020 and $30 million of unrecognized compensation cost related to the restricted stock awards is expected to be recognized primarily through the first quarter of 2021.

21


11. Retirement Programs
The components of net pension and postretirement benefits other than pensions (“OPEB”) costs for the quarter and nine months ended September 30, 2018 and 2017 are shown below:
 
 
Quarter Ended September 30,
 
 
Nine Months Ended September 30,
 
Pensions
 
OPEB
 
 
Pensions
 
OPEB
(Millions of dollars)
2018
 
2017
 
2018
 
2017
 
 
2018
 
2017
 
2018
 
2017
Amount recognized in Operating Profit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service cost
$
12

 
$
12

 
$

 
$

 
 
$
36

 
$
35

 
$
1

 
$
2

Amount recognized in Net pension and OPEB cost (benefit), excluding service cost
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest cost
25

 
25

 
1

 
2

 
 
76

 
76

 
3

 
4

Expected return on plan assets
(42
)
 
(40
)
 

 

 
 
(125
)
 
(120
)
 

 

Net amortization and deferral
18

 
17

 

 

 
 
54

 
51

 
(2
)
 
(2
)
Curtailment gain (a)

 

 

 

 
 

 

 

 
(18
)
Settlement charge
4

 
2

 
$

 
$

 
 
4

 
2

 
$

 
$

 
$
5

 
$
4

 
$
1

 
$
2

 
 
$
9

 
$
9

 
$
1

 
$
(16
)
 Net periodic benefit cost (benefit)
$
17

 
$
16

 
$
1

 
$
2

 
 
$
45

 
$
44

 
$
2

 
$
(14
)

(a) The curtailment gain recorded in the first quarter of 2017 resulted from the termination of an OPEB plan in South America.

In the third quarters of 2018 and 2017, a series of lump sum benefit payments made from the U.S. supplemental pension plan and an international pension plan, respectively, triggered settlements of the related pension obligations. Accordingly, Praxair recorded pension settlement charges of $4 million ($3 million after-tax or $0.01 per diluted share) and $2 million ($1 million after-tax or less than $0.01 per diluted share) in 2018 and 2017, respectively.
Praxair estimates that 2018 required contributions to its pension plans will be in the range of $20 million to $25 million, of which $17 million have been made through September 30, 2018.


22


12. Commitments and Contingencies
Contingent Liabilities
Praxair is subject to various lawsuits and government investigations that arise from time to time in the ordinary course of business. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Praxair has strong defenses in these cases and intends to defend itself vigorously. It is possible that the company may incur losses in connection with some of these actions in excess of accrued liabilities. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a significant impact on the company’s reported results of operations in any given period (see Note 17 to the consolidated financial statements of Praxair’s 2017 Annual Report on Form 10-K).
Significant matters are:
During May 2009, the Brazilian government published Law 11941/2009 instituting a new voluntary amnesty program (“Refis Program”) which allowed Brazilian companies to settle certain federal tax disputes at reduced amounts. During the 2009 third quarter, Praxair decided that it was economically beneficial to settle many of its outstanding federal tax disputes and such disputes were enrolled in the Refis Program, subject to final calculation and review by the Brazilian federal government. The Company recorded estimated liabilities based on the terms of the Refis Program. Since 2009, Praxair has been unable to reach final agreement on the calculations and initiated litigation against the government in an attempt to resolve certain items. Open issues relate to the following matters: (i) application of cash deposits and net operating loss carryforwards to satisfy obligations, and (ii) the amount of tax reductions available under the Refis Program. It is difficult to estimate the timing of resolution of legal matters in Brazil.
At September 30, 2018 the most significant non-income and income tax claims in Brazil, after enrollment in the Refis Program, relate to state VAT tax matters and a federal income tax matter where the taxing authorities are challenging the tax rate that should be applied to income generated by a subsidiary company. The total estimated exposure relating to such claims, including interest and penalties, as appropriate, is approximately $205 million. Praxair has not recorded any liabilities related to such claims based on management judgments, after considering judgments and opinions of outside counsel. Because litigation in Brazil historically takes many years to resolve, it is very difficult to estimate the timing of resolution of these matters; however, it is possible that certain of these matters may be resolved within the near term. The company is vigorously defending against the proceedings.
On September 1, 2010, CADE (Brazilian Administrative Council for Economic Defense) announced alleged anticompetitive activity on the part of five industrial gas companies in Brazil and imposed fines on all five companies. Originally, CADE imposed a civil fine of R$2.2 billion Brazilian reais (US$550 million) against White Martins, the Brazil-based subsidiary of Praxair, Inc. In response to a motion for clarification, the fine was reduced to R$1.7 billion Brazilian reais (US$425 million) due to a calculation error made by CADE. The amount of the fine is subject to indexation using SELIC. On September 2, 2010, Praxair issued a press release and filed a report on Form 8-K rejecting all claims and stating that the fine represents a gross and arbitrary disregard of Brazilian law.
On October 19, 2010, White Martins filed an annulment petition (“appeal”) with the Federal Court in Brasilia seeking to have the fine against White Martins entirely overturned. In order to suspend payment of the fine pending the completion of the appeal process, Brazilian law required that the company tender a form of guarantee in the amount of the fine as security. Initially, 50% of the guarantee was satisfied by letters of credit with a financial institution and 50% by equity of a Brazilian subsidiary. On April 15, 2016, the Ninth Federal Court in Brasilia allowed White Martins to withdraw and cancel the letters of credit. Accordingly, the guarantee is currently satisfied solely by equity of a Brazilian subsidiary.
On September 14, 2015, the Ninth Federal Court of Brasilia overturned the fine against White Martins and declared the original CADE administrative proceeding to be null and void. On June 30, 2016, CADE filed an appeal against this decision with the Federal Circuit Court in Brasilia.
Praxair strongly believes that the allegations are without merit and that the fine will be entirely overturned during the appeal process. The company further believes that it has strong defenses and will vigorously defend against the allegations and related fine up to such levels of the Federal Courts in Brazil as may be necessary. Because appeals in Brazil historically take many years to resolve, it is very difficult to estimate when the appeal will be finally decided. Based on management judgments, after considering judgments and opinions of outside counsel, no reserve has been recorded for this proceeding as management does not believe that a loss is probable.

23


13. Segments
For a description of Praxair’s operating segments, refer to Note 18 to the consolidated financial statements of Praxair’s 2017 Annual Report on Form 10-K.
Sales and operating profit by segment for the quarters and nine months ended September 30, 2018 and 2017 are shown below. 2017 segment operating profit has been reclassified to conform with current year presentation as a result of the adoption of new accounting guidance on the presentation of net periodic pension and postretirement benefit costs (see Note 1).

  
Quarter Ended September 30,
 
Nine Months Ended September 30,
(Millions of dollars)
2018
 
2017
 
2018
 
2017
SALES(a) 
 
 
 
 
 
 
 
North America
$
1,613

 
$
1,518

 
$
4,770

 
$
4,481

Europe
425

 
407

 
1,297

 
1,146

South America
329

 
389

 
1,043

 
1,131

Asia
487

 
451

 
1,465

 
1,268

Surface Technologies
170

 
157

 
509

 
458

Total sales
$
3,024

 
$
2,922

 
$
9,084

 
$
8,484

  
Quarter Ended September 30,
 
Nine Months Ended September 30,
(Millions of dollars)
2018
 
2017
 
2018
 
2017
OPERATING PROFIT
 
 
 
 
 
 
 
North America
$
420

 
$
386

 
$
1,258

 
$
1,121

Europe
81

 
79

 
248

 
220

South America
57

 
66

 
167

 
178

Asia
110

 
88

 
321

 
243

Surface Technologies
32

 
27

 
91

 
78

Segment operating profit
700

 
646

 
2,085

 
1,840

Transaction costs and other charges (Note 2)
(31
)
 
(14
)
 
(74
)
 
(35
)
Total operating profit
$
669

 
$
632

 
$
2,011

 
$
1,805

 
(a)
Sales reflect external sales only. Intersegment sales, primarily from North America to other segments, were not material.


24



14. Equity and Redeemable Noncontrolling Interests
Equity
A summary of the changes in total equity for the quarters and nine months ended September 30, 2018 and 2017 is provided below:

Quarter Ended September 30,
(Millions of dollars)
2018
 
2017
Activity
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
 
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
Balance, beginning of period
$
6,027

 
$
501

 
$
6,528

 
$
5,807

 
$
453

 
$
6,260

Net income (a)
461

 
19

 
480

 
419

 
16

 
435

Other comprehensive income (loss)
(60
)
 
(7
)
 
(67
)
 
219

 
10

 
229

Noncontrolling interests:
 
 
 
 
 
 
 
 
 
 
 
Additions (reductions)

 

 

 

 
2

 
2

Dividends and other capital changes

 
(10
)
 
(10
)
 

 
(6
)
 
(6
)
Redemption value adjustments
(1
)
 

 
(1
)
 

 

 

Dividends to Praxair, Inc. common stock holders ($0.825 per share in 2018 and $0.7875 per share in 2017)
(238
)
 

 
(238
)
 
(225
)
 

 
(225
)
Issuances of common stock:
 
 
 
 
 
 
 
 
 
 
 
For the dividend reinvestment and stock purchase plan
2

 

 
2

 
2

 

 
2

For employee savings and incentive plans
23

 

 
23

 
18

 

 
18

Purchases of common stock
(1
)
 

 
(1
)
 

 

 

Share-based compensation
19

 

 
19

 
16

 

 
16

Balance, end of period
$
6,232

 
$
503

 
$
6,735

 
$
6,256

 
$
475

 
$
6,731


25


 
Nine Months Ended September 30,
(Millions of dollars)
2018
 
2017
Activity
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
 
Praxair, Inc.
Shareholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
Balance, beginning of period
$
6,018

 
$
493

 
$
6,511

 
$
5,021

 
$
420

 
$
5,441

Net income (a)
1,403

 
46

 
1,449

 
1,214

 
44

 
1,258

Other comprehensive income (loss)
(558
)
 
(17
)
 
(575
)
 
575

 
28

 
603

Noncontrolling interests:
 
 
 
 
 
 
 
 
 
 
 
Additions (reductions)

 
7

 
7

 

 
9

 
9

Dividends and other capital changes

 
(26
)
 
(26
)
 

 
(26
)
 
(26
)
Redemption value adjustments
(3
)
 

 
(3
)
 

 

 

Dividends to Praxair, Inc. common stock holders ($2.475 per share in 2018 and $2.36 per share in 2017)
(712
)
 

 
(712
)
 
(675
)
 

 
(675
)
Issuances of common stock: